Armata Pharmaceuticals In...

AMEX: ARMP · Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT

Armata Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-25.71M -426K -18.92M -41.36M -67.04M -79.58M -69.05M -59.51M -36.97M -42.63M -36.92M -32.65M -29.45M -26.43M -23.16M -23.73M -24.08M -22.6M
Depreciation & Amortization
1.44M 1.39M 1.32M 1.24M 1.15M 1.06M 972K 924K 929K 896K 892K 924K 1.01M 1.11M 1.17M 1.17M 1.12M 1.1M
Stock-Based Compensation
2.38M 3.14M 2.89M 2.73M 1.69M 615K 938K 1.56M 2.78M 3.47M 3.1M 2.95M 2.58M 2.53M 2.88M 3.08M 3.27M 3.27M
Other Working Capital
-508K 1.22M 1.66M -1.06M 515K -3.9M -9.69M -14.78M -18.1M -13.75M -4.17M -2.94M 243K 772K -3M -419K -11K -936K
Other Non-Cash Items
-6.75M -37.04M -20.75M 2.81M 23.91M 38.03M 25.91M 15.24M -115K 7.22M 4.06M 401K -1.92M -3.23M -3.16M 231K 390K 531K
Deferred Income Tax
n/a n/a n/a -419K 3.44M 3.44M 3.44M 3.42M -2.76M -4.06M -4.06M -401K 1.2M 2.5M 1.92M -1.74M -1.02M -1.02M
Change in Working Capital
-2.94M -1.6M -2.1M -2.73M -1.7M -4.01M -9.65M -11.44M -14.32M -11.43M 439K -1.82M 1.37M 1.9M -3.22M -284K 124K -801K
Operating Cash Flow
-31.58M -34.55M -37.55M -37.73M -38.55M -40.44M -47.42M -49.8M -50.45M -46.54M -32.48M -30.59M -25.23M -21.61M -23.57M -21.28M -20.2M -19.51M
Capital Expenditures
-511K -1.73M -1.88M -4.36M -7.53M -6.38M -8.14M -5.29M -3.07M -3.98M -2.21M -2.89M -2.18M -1.24M -1.3M -1.44M -941K -1.02M
Cash Acquisitions
n/a n/a n/a 10K 10K 10K 10K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-511K -1.73M -1.88M -4.35M -7.52M -6.37M -8.13M -5.29M -3.07M -3.98M -2.21M -2.89M -2.18M -1.24M -1.3M -1.44M -941K -1.02M
Debt Repayment
-24.89M -24.89M n/a 34.89M 59.69M 59.32M 54.03M 54.03M 29.23M 29.59M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-14K -14K n/a -43K -43K -43K -43K n/a n/a -146K -146K -146K -146K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
34.89M 34.89M 34.89M n/a n/a n/a n/a -500K -469K -469K -469K 113K 168K 168K -801K -451K -477K 241K
Financial Cash Flow
9.93M 10.01M 34.96M 34.91M 59.78M 59.33M 53.99M 53.53M 28.76M 28.98M 44.02M 51.55M 51.61M 51.57M 25.52M 18.91M 18.89M 19.38M
Net Cash Flow
-22.17M -26.26M -4.47M -7.06M 13.81M 12.62M -1.47M -1.56M -24.76M -21.54M 9.32M 18.07M 24.2M 28.71M 639K -3.81M -2.25M -1.15M
Free Cash Flow
-32.09M -36.27M -39.43M -42.09M -46.08M -46.82M -55.57M -55.09M -53.52M -50.52M -34.69M -33.49M -27.41M -22.86M -24.88M -22.72M -21.14M -20.53M